January 6, 2017American Journal of Hypertension
Malignant Hypertension Revisited—Does This Still Exist?
Key result
Malignant hypertension remains a clinically relevant and challenging entity, with improving prognosis but no significant change in incidence, often diagnosed only when target organ damage occurs.
Structured PICO
P
Population
Patients with malignant or accelerated hypertension (defined clinically by diastolic blood pressure above 130 mm Hg accompanied by bilateral retinal hemorrhages and/or exudates, with or without papilledema)
Malignant hypertension remains a clinically relevant and challenging condition that must be considered during the assessment of patients with poorly controlled hypertension.
Authors
Discussion
No takes yet. Share an insight, caveat, or question.
Implication
Early detection of malignant hypertension before organ damage warrants renewed clinical focus; leaves open whether incidence trends can be altered.
Cite This Study
Shantsila et al. (2017) conducted a review in Malignant hypertension. Malignant hypertension was evaluated. Malignant hypertension remains a clinically relevant and challenging entity, with improving prognosis but no significant change in incidence, often diagnosed only when target organ damage occurs.